TrialJournal of neurology2024

JEWELFISH: 24-month results from an open-label study in non-treatment-naïve patients with SMA receiving treatment with risdiplam.

Claudia A Chiriboga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.